Cargando…

Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?

PURPOSE: To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. METHODS: The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/modera...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasar, Emre, Ozger, Hasan Selcuk, Yeter, Hacı Hasan, Yildirim, Cigdem, Osmanov, Zakir, Cetin, Taha Enes, Akcay, Omer Faruk, Bukan, Neslihan, Derici, Ulver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252694/
https://www.ncbi.nlm.nih.gov/pubmed/34213713
http://dx.doi.org/10.1007/s11255-021-02937-0
_version_ 1783717352834072576
author Yasar, Emre
Ozger, Hasan Selcuk
Yeter, Hacı Hasan
Yildirim, Cigdem
Osmanov, Zakir
Cetin, Taha Enes
Akcay, Omer Faruk
Bukan, Neslihan
Derici, Ulver
author_facet Yasar, Emre
Ozger, Hasan Selcuk
Yeter, Hacı Hasan
Yildirim, Cigdem
Osmanov, Zakir
Cetin, Taha Enes
Akcay, Omer Faruk
Bukan, Neslihan
Derici, Ulver
author_sort Yasar, Emre
collection PubMed
description PURPOSE: To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. METHODS: The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/moderate COVID-19 infection between March and September 2020 and healthy individuals as a control group (n = 20). The uKIM-1, serum creatinine, cystatin C, spot urine protein, creatinine, and albumin levels of the patients were evaluated again after an average of 21 days. RESULTS: The median (interquartile range) uKIM-1 level at the time of presentation was 246 (141–347) pg/mL in the proteinuric group, 83 (29–217) pg/mL in the non-proteinuric group, and 55 (21–123) pg/mL in the control group and significantly high in the proteinuric group than the others (p < 0.001). Creatinine and cystatin C were significantly higher in the proteinuric group than in the group without proteinuria, but none of the patients met the KDIGO-AKI criteria. uKIM-1 had a positive correlation with PCR, non-albumin proteinuria, creatinine, cystatin C, CRP, fibrinogen, LDH, and ferritin, and a negative correlation with eGFR and albumin (p < 0.05). In the multivariate regression analysis, non-albumin proteinuria (p = 0.048) and BUN (p = 0.034) were identified as independent factors predicting a high uKIM-1 level. After 21 ± 4 days, proteinuria regressed to normal levels in 20 (67%) patients in the proteinuric group. In addition, the uKIM-1 level, albuminuria, non-albumin proteinuria, and CRP significantly decreased. CONCLUSIONS: Our findings support that the kidney is one of the target organs of the COVID-19 and it may cause proximal tubule injury even in patients that do not present with AKI or critical/severe COVID-19 infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11255-021-02937-0.
format Online
Article
Text
id pubmed-8252694
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-82526942021-07-02 Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection? Yasar, Emre Ozger, Hasan Selcuk Yeter, Hacı Hasan Yildirim, Cigdem Osmanov, Zakir Cetin, Taha Enes Akcay, Omer Faruk Bukan, Neslihan Derici, Ulver Int Urol Nephrol Nephrology - Original Paper PURPOSE: To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. METHODS: The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/moderate COVID-19 infection between March and September 2020 and healthy individuals as a control group (n = 20). The uKIM-1, serum creatinine, cystatin C, spot urine protein, creatinine, and albumin levels of the patients were evaluated again after an average of 21 days. RESULTS: The median (interquartile range) uKIM-1 level at the time of presentation was 246 (141–347) pg/mL in the proteinuric group, 83 (29–217) pg/mL in the non-proteinuric group, and 55 (21–123) pg/mL in the control group and significantly high in the proteinuric group than the others (p < 0.001). Creatinine and cystatin C were significantly higher in the proteinuric group than in the group without proteinuria, but none of the patients met the KDIGO-AKI criteria. uKIM-1 had a positive correlation with PCR, non-albumin proteinuria, creatinine, cystatin C, CRP, fibrinogen, LDH, and ferritin, and a negative correlation with eGFR and albumin (p < 0.05). In the multivariate regression analysis, non-albumin proteinuria (p = 0.048) and BUN (p = 0.034) were identified as independent factors predicting a high uKIM-1 level. After 21 ± 4 days, proteinuria regressed to normal levels in 20 (67%) patients in the proteinuric group. In addition, the uKIM-1 level, albuminuria, non-albumin proteinuria, and CRP significantly decreased. CONCLUSIONS: Our findings support that the kidney is one of the target organs of the COVID-19 and it may cause proximal tubule injury even in patients that do not present with AKI or critical/severe COVID-19 infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11255-021-02937-0. Springer Netherlands 2021-07-02 2022 /pmc/articles/PMC8252694/ /pubmed/34213713 http://dx.doi.org/10.1007/s11255-021-02937-0 Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Nephrology - Original Paper
Yasar, Emre
Ozger, Hasan Selcuk
Yeter, Hacı Hasan
Yildirim, Cigdem
Osmanov, Zakir
Cetin, Taha Enes
Akcay, Omer Faruk
Bukan, Neslihan
Derici, Ulver
Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?
title Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?
title_full Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?
title_fullStr Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?
title_full_unstemmed Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?
title_short Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?
title_sort could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate covid-19 infection?
topic Nephrology - Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252694/
https://www.ncbi.nlm.nih.gov/pubmed/34213713
http://dx.doi.org/10.1007/s11255-021-02937-0
work_keys_str_mv AT yasaremre couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection
AT ozgerhasanselcuk couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection
AT yeterhacıhasan couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection
AT yildirimcigdem couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection
AT osmanovzakir couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection
AT cetintahaenes couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection
AT akcayomerfaruk couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection
AT bukanneslihan couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection
AT dericiulver couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection